Evidence map›Paper›PMID 42319537›Full record

ReviewJournal of robotic surgery2026

Rethinking health technology assessment in robotic surgery: an EFISDS-TROGSS position paper. Official position paper of the European Federation - International Society for Digestive Surgery (EFISDS) and The Robotic Global Surgical Society (TROGSS).

Luigi Marano, Rodolfo J Oviedo, Gennaro Nappo, Francesco Paolo Prete, Beniamino Pascotto, Adel Abou-Mrad, Yogesh Vashist

Abstract readConsensus StatementReview
PubMed Publisher
In one paragraph

Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luigi MaranoDepartment of Medicine, Academy of Applied Medical and Social Sciences-AMiSNS (Akademia Medycznych I Spolecznych Nauk Stosowanych), AMiSNS Ul. Lotnicza 3, 82-300, Elbląg, Poland. l.marano@amisns.edu.pl.ORCID http://orcid.org/0000-0002-9777-9588
Rodolfo J OviedoDepartment of Surgery, Nacogdoches Medical Center, 4948 NE Stallings Dr Nacogdoches, Nacogdoches, TX, 75965, USA. roviedo3@central.uh.edu.ORCID http://orcid.org/0000-0003-3784-6555
Gennaro NappoEuropean Federation - International Society for Digestive Surgery (EFISDS), Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0002-6048-898X
Francesco Paolo PreteThe Robotic Global Surgical Society (TROGSS), International, Orléans, France.ORCID http://orcid.org/0000-0003-0426-8752
Beniamino PascottoThe Robotic Global Surgical Society (TROGSS), International, Orléans, France.ORCID http://orcid.org/0000-0003-0864-9819
Adel Abou-MradThe Robotic Global Surgical Society (TROGSS), International, Orléans, France.ORCID http://orcid.org/0000-0003-3408-4540
Yogesh VashistEuropean Federation - International Society for Digestive Surgery (EFISDS), Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0003-2030-6712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robotic-assisted surgery (RAS) has evolved from a procedural innovation into an increasingly integrated component of contemporary digital surgical ecosystems. Nevertheless, most current Health Technology Assessment (HTA) frameworks continue to evaluate robotic systems primarily through comparator-based models focused on isolated perioperative and oncological outcomes. In this EFISDS-TROGSS position paper, we critically examine the methodological limitations of conventional HTA paradigms when applied to robotic surgical platforms, using the recent Italian AGENAS appraisal as a representative case study. While the AGENAS document represents one of the most comprehensive national evaluations of RAS performed to date, its heterogeneous recommendations across procedures highlight unresolved tensions regarding perioperative benefit, real-world implementation, learning curves, organizational impact, and long-term healthcare value. We argue that RAS should increasingly be interpreted not simply as a surgical device, but as a platform technology interacting with simulation-based training, digital infrastructure, surgical data science, artificial intelligence, telecommunication systems, and institutional organization. Rather than a surgical device alone, RAS should be interpreted and regarded as a combination of technological advances and approaches that integrate various degrees of artificial intelligence autonomy, image navigation, telesurgery, and other benefits to empower the surgical team. Conventional HTA models, originally developed for relatively discrete therapeutic interventions, may incompletely capture the multidimensional interaction between robotic technologies and modern healthcare systems. Particular attention is dedicated to real-world evidence, implementation maturity, reimbursement limitations, and the growing mismatch between current Diagnosis-Related Group (DRG) structures and technologically integrated surgical care. Finally, we propose more flexible and multidimensional assessment frameworks integrating procedural outcomes with organizational sustainability, digital interoperability, workforce implications, and longitudinal healthcare value.

Indexed as

Robotic Surgical ProceduresTechnology Assessment, BiomedicalArtificial IntelligenceEuropeHumansSocieties, MedicalValue-Based Health CareDigital surgeryHealthcare systems integrationHealth technology assessmentReal-world evidenceRobotic-assisted surgerySurgical innovation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.